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In the lungs, parasympathetic nerves provide the dominant control of airway smooth muscle (19) . Stimulation of these nerves releases ACh onto postjunctional M 3 muscarinic receptors on airway smooth muscle, causing contraction and bronchoconstriction (22) . At the same time, ACh feeds back onto prejunctional inhibitory M 2 muscarinic receptors (M 2 Rs) on the nerves, inhibiting further release of ACh and limiting bronchoconstriction (9) . Dysfunction of these neuronal M 2 Rs increases ACh release and potentiates vagally induced bronchoconstriction. Stimulation of the neuronal M 2 Rs with the muscarinic agonist pilocarpine inhibits vagally induced bronchoconstriction by 70-80% by decreasing ACh release (3, 9) . Conversely, blocking the M 2 R with selective antagonists, such as gallamine, markedly increases bronchoconstriction by increasing ACh release.
Virus infection causes neuronal M 2 R dysfunction and airway hyperreactivity (8) . The mechanism by which this occurs is only partially understood. Studies in guinea pigs suggest that viruses can inhibit M 2 R function via inflammatory cells but also cause loss of M 2 R function that is independent of airway inflammation (10) .
Rhinovirus, the cause of the common cold, causes primarily upper respiratory tract inflammation and epithelial damage, and yet it is implicated in the majority of virus-associated asthma attacks (2, 16, 20) . Although rhinovirus has been shown, by in situ hybridization, to infect bronchial epithelium (21) , it replicates principally in the upper airway and has been difficult to culture from the lower airway (5). Furthermore, sputum from allergic subjects with experimental rhinovirus infection has shown either no (12) or only modest increases in inflammatory cells (11) .
We suggest that changes in neuronal M 2 R expression are mediated by cytokines produced at the sites of infection, which, in the case of rhinovirus, is primarily in the upper airways. These cytokines may then circulate to the airway nerves, where they decrease expression or function of the M 2 R and cause airway hyperreactivity. Thus, in the absence of airway inflammation or local infection, viruses can induce changes resulting in increased bronchoconstriction. Double-stranded RNA (dsRNA) is produced as a replicative intermediate during viral infection. dsRNA is not normally present in the cytoplasm of mammalian cells. By binding to and activating various host enzymes, it can serve as a potent stimulus to innate host defenses including production of type I interferons (IFNs) (14) .
Of primary importance in the host response to viral infection is the transcriptional activation of genes coding for the type I IFNs ␣ and ␤. These IFNs confer their antiviral effects through the induction of specific IFNstimulated genes via effects on their common DNA promoter sequence known as the IFN␣/␤-stimulated response element (23) . The response to dsRNA involves release of IFNs, among other cytokines, that limit viral replication (14) .
In this study, we tested whether dsRNA causes airway hyperreactivity and M 2 R dysfunction in vivo, similar to the effects of virus. Direct administration of dsRNA via inhalation or aerosol could cause airway irritation and inflammation and subsequent hyperreactivity. To avoid these complicating effects, dsRNA was given by intraperitoneal injection. This method of exposure establishes a clear anatomic separation between the area of inflammation and the site of neuronal M 2 R dysfunction.
METHODS
Animals. Specific pathogen-free female Dunkin-Hartley guinea pigs (300-400 g; supplied by Hilltop Animal Farms, Scottsdale, PA) were shipped in filtered crates and housed in isolation hoods with high-efficiency particulate-filtered air. Guinea pigs were fed a normal diet (Prolab, Agway, Syracuse, NY). Animals were handled in accordance with the standards established by the USA Animal Welfare Acts set forth in National Institute of Health guidelines and the Policy and Procedures Manual published by the Johns Hopkins University School of Hygiene and Public Health Animal Care and Use Committee.
dsRNA exposure. Polyinosinic-polycytidylic acid (Poly[I]-Poly[C]) sodium salt (dsRNA) (Sigma Chemical, St. Louis, MO) was dissolved in sterile water to a concentration of 1 mg/ml. Guinea pigs were injected intraperitoneally with dsRNA (1 mg/kg) on 2 consecutive days. M 2R function was tested 1 day after the second injection. Control animals were injected with sterile water (1 ml/kg).
Measurements of pulmonary inflation pressure. Experiments were conducted 1 day after dsRNA treatment. The guinea pigs were anesthetized with urethane (1.7 g/kg ip). This dose produces a deep anesthesia lasting 8-10 h, although none of these experiments lasted longer than 3 h. Both jugular veins were cannulated for the administration of drugs. One internal carotid artery was cannulated for measurement of blood pressure by using a DTX pressure transducer (Viggo-Spectramed, Oxnard, CA), and the heart rate was derived from the blood pressure tracing by use of a tachograph. The trachea was cannulated, and the animals were ventilated with a positive-pressure, constant-volume rodent respirator (Harvard Apparatus, South Natick, MA) at a tidal volume of 10 ml/kg and a respiratory rate of 100 breaths/min. Animals were paralyzed with succinylcholine (10 g ⅐ kg Ϫ1 ⅐ min Ϫ1 iv). All animals were pretreated with guanethidine (10 mg/kg) to deplete norepinephrine. Pulmonary inflation pressure (Ppi) was measured at the trachea via a DTX pressure transducer. All signals were recorded on a polygraph (Grass Instruments, Quincy, MA). Bronchoconstriction was measured as the increase in Ppi above the baseline inflation pressure produced by the ventilator. The output Ppi signal from the driver of one channel was fed to the preamplifier of a different channel on the polygraph so that increases over baseline could be measured at a higher gain. With this method, increases in Ppi as small as 2-3 mmH 2O can be accurately recorded. Baseline inflation pressure ranged from 90 to 140 mmH 2O.
Studies of vagal responsiveness. Both vagus nerves were cut, and the distal ends were placed on shielded electrodes immersed in mineral oil. Electrical stimulation of both vagi produced bronchoconstriction and bradycardia. The vagus nerves were stimulated at frequencies ranging from 2.0 to 25.0 Hz for 5 s at 120-s intervals, with both pulse duration (0.2 ms) and voltage (10.0 V) kept constant between groups. After the completion of each experiment, atropine (1 mg/kg iv) was administered to confirm that bronchoconstrictions were due to cholinergic nerve stimulation. Changes in Ppi were recorded on a Grass polygraph as described above.
Studies of neuronal M 2R function. Baseline responses to electrical stimulation of the vagus nerves were obtained by stimulating both vagus nerves simultaneously at 55-s intervals (2 Hz, 0.2 ms, 7.5-30 V, 44 pulses/train). The function of autoreceptors is frequency dependent. Stimulation of M2Rs by endogenous ACh is greatest at high frequencies of stimulation. Therefore, the ability of exogenous agonists to inhibit vagally induced bronchoconstriction via stimulation of M2Rs is more readily apparent at low frequencies of stimulation (9) . Thus the studies with the muscarinic agonist pilocarpine were carried out at 2 Hz. The voltage was chosen at the beginning of each experiment (within a range of 7.5-30.0 V; mean V) to give an increase in pulmonary inflation pressure of ϳ20 mmH2O (21.4 Ϯ 0.75 mmH2O). Cumulative doses of pilocarpine (0.1-100 g/kg iv) were administered, and the effect on vagally induced bronchoconstriction was measured. Pilocarpine doses of 30-100 g/kg produced a small, transient bronchoconstriction. Therefore, the effect of these doses of pilocarpine on vagally induced bronchoconstriction was measured after the Ppi had returned to baseline. The results are expressed as a ratio of bronchoconstriction in the presence of pilocarpine to the bronchoconstriction in the absence of pilocarpine. Thus a ratio Ͻ1 would indicate that pilocarpine was inhibiting vagally induced bronchoconstriction, demonstrating functional M2Rs. After completion of each experiment, atropine (1 mg/kg iv) was given to confirm that bronchoconstrictions were due to release of ACh onto muscarinic receptors on the smooth muscle.
Studies of postjunctional muscarinic receptor function. The function of muscarinic receptors on airway smooth muscle was tested in vagotomized guinea pigs by measuring bronchoconstriction in response to increasing doses of ACh (1-10 g/kg iv).
Studies of M2R function on cardiac myocytes. Binding of ACh to muscarinic M2Rs on cardiac muscle cells causes a fall in heart rate. However, stimulation of M2Rs on the parasympathetic nerves supplying these cardiac muscle cells limits ACh release in a manner identical to the M2Rs on parasympathetic nerves supplying bronchial smooth muscle. The function of these M2Rs was tested in vagotomized guinea pigs by measuring the fall in heart rate in response to increasing doses of ACh (1-10 g/kg iv). A smaller fall in heart rate in response to intravenous ACh in dsRNA-treated animals compared with controls would suggest dysfunction of M2Rs on the cardiac muscle. Next, the M2Rs on cardiac muscle cells were tested with increasing frequency of electrical stimulation (2-25 Hz) of the vagus nerves as described above. In this experiment, a greater fall in heart rate, in response to increasing frequency of electrical stimulation of the vagi, in dsRNA-treated animals would suggest dysfunction of the neuronal M 2Rs.
Bronchoalveolar lavage. At the end of each experiment, bronchoalveolar lavage was performed in situ via the tracheal cannula. The lungs were lavaged with five 10-ml aliquots of PBS. The recovered lavage fluid (35-45 ml) was centrifuged (350 g for 10 min), and the cells were resuspended in 10 ml of PBS. Cells were counted by using a Neubauer hemocytometer (Hausser Scientific, Hoarsham, PA). Aliquots of the cell suspension were cytospun onto glass slides, stained with Diff-Quik (Baxter Healthcare, McGaw Park, IL), and counted to obtain differential cell counts.
Drugs and reagents. ACh, atropine, dsRNA, guanethidine, heparin, pilocarpine, succinylcholine, and urethane were purchased from Sigma Chemical. All drugs were dissolved and diluted in 0.9% NaCl or PBS.
Statistics. All data are expressed as means Ϯ SE. ACh, frequency, and pilocarpine responses were analyzed by twoway ANOVA for repeated measures. Baseline heart rates, blood pressures, pulmonary inflation pressures, and changes in pulmonary inflation pressure (before pilocarpine administration), histological measurements, and bronchoalveolar lavage were analyzed by ANOVA (Statview 4.5, Abacus Concepts, Berkeley, CA). A P value of 0.05 was considered significant.
RESULTS

Baseline physiological parameters.
Treatment with dsRNA intraperitoneally on 2 consecutive days did not affect the baseline Ppi, heart rate, or blood pressure.
Response to vagal stimulation. Electrical stimulation of the vagus nerves caused frequency-dependent bronchoconstriction (Fig. 1) M 2 R function. In control guinea pigs, pilocarpine inhibited vagally induced bronchoconstriction in a dose-dependent manner ( Fig. 2) with maximal inhibition of 60.0 Ϯ 3.7% at the 100 g/kg dose, demonstrating a functional M 2 R. In contrast, in animals treated with dsRNA the maximal inhibition of vagally induced bronchoconstriction by pilocarpine was 17.6 Ϯ 8.5%, demonstrating that the M 2 Rs were dysfunctional.
M 3 receptor function. There was no effect of dsRNA on the response to intravenous ACh, demonstrating that the function of M 3 muscarinic receptors on airway smooth muscle was normal (Fig. 3) . This unchanged response to intravenous ACh also demonstrates that smooth muscle contraction was unaffected by dsRNA.
Bronchoalveolar lavage. Treatment of guinea pigs with dsRNA did not change total cells recovered in bronchoalveolar lavage compared with controls. The differential counts were likewise unaffected by dsRNA. (Fig. 4) .
Heart rate responses. dsRNA-treated guinea pigs had a significantly greater fall in heart rate, compared with control animals, in response to increasing frequency of electrical stimulation of the vagus (Fig. 5A ). In contrast, the fall in heart rate with intravenous ACh was not affected by treatment with dsRNA (Fig. 5B ).
DISCUSSION
Respiratory virus infection causes airway hyperreactivity and loss of M 2 R function (8) . In guinea pigs depleted of leukocytes before viral infection, M 2 R function is preserved only in animals with low viral titers. Leukocyte-depleted animals with high viral titers had loss of M 2 R function (10) . This suggests that viruses have effects on M 2 Rs that are mediated by leukocytes as well as direct effects that are independent of leukocytes.
We used a synthetic, nonsense double-stranded RNA as a surrogate for virus in an attempt to bypass virusinduced inflammation and to incite the innate host immune system in guinea pigs. dsRNA increased bronchoconstriction in response to electrical stimulation of the vagus nerves (Fig. 1) . Potentiation of vagally induced bronchoconstriction was not due to increased M 3 muscarinic receptor activity on airway smooth muscle or to nonspecific increase in smooth muscle contractility because ACh-induced bronchoconstriction was not different between control and dsRNA-treated guinea pigs (Fig. 3) . Thus vagally mediated hyperreactivity is due to increased release of ACh. This effect occurred in the absence of airway inflammation (Fig. 4) .
In control guinea pigs, pilocarpine inhibited vagally induced bronchoconstriction in a dose-dependent manner (Fig. 2) confirming that the neuronal M 2 Rs were functional (9) . In contrast, the ability of pilocarpine to inhibit vagally mediated bronchoconstriction was markedly decreased in guinea pigs treated with intraperitoneal dsRNA (Fig. 2) . Thus dsRNA inhibits neuronal M 2 R function in the lung. M 2 R dysfunction caused by dsRNA is independent of airway inflammation (Fig. 4) . Frequency-induced bradycardia is significantly greater (P ϭ 0.014) in dsRNAtreated guinea pigs (F, n ϭ 7) than in controls (E, n ϭ 9). B: intravenous ACh (1-10 g/kg) stimulates postjunctional M2Rs on cardiac myocytes, causing a dosedependent fall in heart rate. ACh-induced bradycardia is not different in controls (E, n ϭ 7) compared with dsRNA-treated animals (F, n ϭ 9). Values are means Ϯ SE; bpm, beats/min.
There are also M 2 Rs both on the cardiac myocytes (postjunctional) and on the parasympathetic nerves supplying the heart (prejunctional) (13) . Stimulation of the postjunctional M 2 Rs causes a fall in heart rate. The prejunctional M 2 Rs function to limit ACh release. Vagally mediated bradycardia was increased by dsRNA (Fig. 5A) . In contrast, intravenous ACh-induced bradycardia was not affected by dsRNA (Fig. 5B) . This demonstrates that postjunctional M 2 Rs on cardiac muscle were not affected by treatment with dsRNA. Thus the accentuated vagally mediated bradycardia in dsRNAtreated animals reflects increased ACh release. This is consistent with loss of M 2 R function on the parasympathetic nerves supplying the heart (18).
DsRNA causes M 2 R dysfunction on the parasympathetic nerves supplying both the lungs and the heart. In contrast, postjunctional muscarinic receptors, whether M 2 or M 3 , were not affected by dsRNA. The finding of normal M 2 R function on cardiac muscle in animals with loss of neuronal M 2 R function demonstrates that the M 2 Rs undergo tissue-specific regulation.
Viral infection causes M 2 R dysfunction and airway hyperreactivity (8) . Although rhinoviruses cause predominately upper airway infection, they are implicated more often than any other virus in exacerbation of asthma. Despite very high viral titers in nasal lavage, Calhoun et al. (5) , in studies with experimental intranasal rhinovirus infection, were unable to culture virus from the lower airways. Only recently has rhinovirus been clearly shown to infect of bronchial epithelium after nasal inoculation. Using in situ hybridization techniques in bronchial biopsy tissue from subjects exposed to rhinovirus 16, Papadopoulos et al. (21) demonstrated virus localized to the columnar epithelium and basal cell layer. These results were confirmed by RT-PCR for rhinovirus 16. However, lower airway inflammatory responses to rhinovirus infection have generally been absent or modest (11, 12) . Viral infection induces an inflammatory cascade in the host. Clearly, initiation of this response requires recognition that virus is present. dsRNA, a molecule produced by viruses and not normally found in the cytoplasm of mammalian cells, is a powerful stimulus to innate cellular defense mechanisms. RNA viruses (including rhinovirus) produce dsRNA during genomic replication. DNA viruses can also produce dsRNA through the erroneous simultaneous transcription of sense and antisense DNA (14) .
DsRNA activates several protein kinases including protein kinase R, a serine/threonine kinase that is induced by type I IFNs (25) . These kinases in turn activate a variety of transcription factors, including nuclear factor-B. Activated nuclear factor-B translocates into the nucleus and induces the transcription of a number of cellular genes including IFNs, inciting a nonspecific antiviral response (14, 25) . Protein kinase R also phosphorylates (thereby inactivating) eukaryotic initiation factor 2␣, which results in a generalized inhibition of translation. dsRNA also induces 2Ј-5Ј oligoadenylate synthetases, which in turn activate RNaseL, an RNA-degrading enzyme (25) .
IFN-␥ decreases expression of M 2 Rs in primary parasympathetic nerve cells in culture (15) . Although there are distinct effects of the different classes of IFNs on gene expression, there is also a great deal of overlap in the effects caused by the various IFNs (6) . Thus the ability of dsRNA to inhibit neuronal M 2 R function may be due to decreased M 2 R expression by IFNs.
The induction of IFNs through cellular interaction with virally produced dsRNA may be a major mechanism by which rhinoviruses, and other airway viruses, cause M 2 R dysfunction and airway hyperreactivity. Intraperitoneal injection of dsRNA is likely endocytosed by inflammatory cells triggering IFN production (24) . IFN may then circulate systemically to affect muscarinic receptors on the parasympathetic nerves supplying the airways and the heart.
We have shown that double-stranded RNA injected intraperitoneally into guinea pigs results in M 2 R dysfunction and hyperreactivity in the airway in the absence of inflammation. dsRNA also causes dysfunction of the prejunctional muscarinic receptors on parasympathetic nerves supplying the heart. At the same time, the function of the postjunctional muscarinic receptors on the heart is not altered. This shows that M 2 Rs are regulated independently in different tissues.
dsRNA mimics the effects of viral infection in causing M 2 R dysfunction and airway hyperreactivity. Because dsRNA is produced during viral infection, this may be a fundamental mechanism by which viruses cause M 2 R dysfunction. This mechanism may contribute to virus-induced asthma attacks.
